<code id='374D76AB15'></code><style id='374D76AB15'></style>
    • <acronym id='374D76AB15'></acronym>
      <center id='374D76AB15'><center id='374D76AB15'><tfoot id='374D76AB15'></tfoot></center><abbr id='374D76AB15'><dir id='374D76AB15'><tfoot id='374D76AB15'></tfoot><noframes id='374D76AB15'>

    • <optgroup id='374D76AB15'><strike id='374D76AB15'><sup id='374D76AB15'></sup></strike><code id='374D76AB15'></code></optgroup>
        1. <b id='374D76AB15'><label id='374D76AB15'><select id='374D76AB15'><dt id='374D76AB15'><span id='374D76AB15'></span></dt></select></label></b><u id='374D76AB15'></u>
          <i id='374D76AB15'><strike id='374D76AB15'><tt id='374D76AB15'><pre id='374D76AB15'></pre></tt></strike></i>

          knowledge

          knowledge

          author:hotspot    Page View:7822
          Blue Cross Blue Shield website seen on several laptop screens. -- health business coverage from STAT
          Adobe

          A program that undergirds the Affordable Care Act’s health insurance marketplaces continues to bolster the balance sheets of large Blue Cross Blue Shield companies, according to a STAT analysis of new federal data.

          Conversely, that same program — called “risk adjustment” — has created substantial financial burdens for startup insurers including Bright Health Group, which has now exited all health insurance markets, and Friday Health Plans, which has shut down.

          advertisement

          More than two dozen BCBS insurers are projected to collect more than $4.7 billion from competing insurers on the ACA marketplaces, according to the analysis. The biggest amounts are concentrated among a few dominant Blues conglomerates.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK
          JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

          InhonorofJPMWeek,you’rereadingaspecialeditionofourbiotechnewsletter,TheReadout.Tostayontopofthelates

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Ascension's ugly legal battle over care for poor patients in Texas

          Austin,Texashasbecomethegroundsforduelingpowerfulinterestsfightingoverhealthcareservicesforpoorpatie